Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples